SCHEMBL7873837

SCHEMBL7873837

CCN(CC)Cc1cccc(COc2ccc(Cl)c3cc(C(=O)N(C)C(=N)N)[nH]c23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
MDM2 Q00987 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GYS1 P13807 1/20 0.38
MRGPRX4 Q96LA9 11/20 0.37
EGFR P00533 1/20 0.36
ERBB2 P04626 1/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7880877 0.92 RHEB (0.40) ALDH1A1HPGDSMN1; SMN2L3MBTL1
SCHEMBL7884412 0.92 MGMT (0.38) NPC1ALDH1A1MAPTHPGDHTT
SCHEMBL7873387 0.89 MRGPRX4 (0.44) NPC1ALDH1A1MAPTHPGDHTT
SCHEMBL7877796 0.89 GYS1 (0.38) ALDH1A1L3MBTL1GYS1MRGPRX4GRIN2D
SCHEMBL7877609 0.88 HTR2A (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7881174 0.87 LTB4R (0.35) NPC1ALDH1A1MAPTHPGDHTT
SCHEMBL7882405 0.86 GYS1 (0.39) MAPTGYS1MRGPRX4GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL7882091 0.86 MRGPRX4 (0.40) NPC1ALDH1A1MAPTHPGDHTT
Hydrochloric Acid SCHEMBL7877431 0.86 RHEB (0.42) NPC1ALDH1A1MAPTHPGDHTT
SCHEMBL7880027 0.84 RHEB (0.42) NPC1ALDH1A1MAPTHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed